Create Account | Sign In: Author or Forum

Search Symptoms

Category: Family Medicine | Gynecology | Internal Medicine | Nursing | Oncology | Pathology | Pulmonology | Radiology | Surgery | Journal

Back to Journal Articles

Uninsurance Down by One-Third for Cancer Diagnoses in 2014

Last Updated: October 19, 2017.

In the first year of the Affordable Care Act, there was a relative decrease of one-third in uninsurance among adults with new cancer diagnoses, according to a research letter published online Oct. 19 in JAMA Oncology.

THURSDAY, Oct. 19, 2017 (HealthDay News) -- In the first year of the Affordable Care Act (ACA), there was a relative decrease of one-third in uninsurance among adults with new cancer diagnoses, according to a research letter published online Oct. 19 in JAMA Oncology.

Aparna Soni, from Indiana University in Bloomington, and colleagues used data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program for 2010 to 2014 to quantify changes in health insurance coverage under the ACA among patients newly diagnosed with cancer. Data were obtained for 858,193 adults aged 19 to 64 with new cancer diagnoses.

The researchers found that 5.73 percent of these individuals were uninsured before 2014, compared with 3.81 percent in 2014, a 1.92 percentage point decrease (33.51 percent relative decline). There were significant decreases across all stages and sites assessed. The largest absolute decreases were seen for distant disease and lung and bronchial cancer (−3.03 and −2.95 percentage points, respectively); these represented relative declines of −33.26 and −32.67 percent for distant disease and lung and bronchial cancer, respectively. The greatest changes in uninsurance were seen for individuals of Hispanic ethnicity and other race (−39.87 and −46.19 percent, respectively, and for residents of wealthier counties (−36.12 percent).

"Policy changes that reduce Medicaid funding or weaken protections for individuals with pre-existing conditions could be particularly harmful for patients with cancer," the authors write.

Abstract/Full Text (subscription or payment may be required)


Previous: Diabetes Ups Risk of MACE in Acute Coronary Syndromes Next: Gene Tx Approved for Certain Types of B-Cell Lymphoma

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: